The potassium voltage-gated channel KCNH2 is a well-known gene in which mutations induce familial QT interval prolongation. KCNH2 is suggested to be a risk gene for schizophrenia. Additionally, the disturbance of autonomic control, which affects the QT interval, is known in schizophrenia. Therefore, we speculate that schizophrenic patients have characteristic features in terms of the QT interval in addition to the effect of antipsychotic medication. The QT interval of patients with schizophrenia not receiving antipsychotics (n = 85) was compared with that of patients with schizophrenia receiving relatively large doses of antipsychotics (n = 85) and healthy volunteers (n = 85). The QT interval was corrected using four methods (Bazett, Fridericia, Framingham or Hodges method). In ANCOVA with age and heart rate as covariates, patients not receiving antipsychotic treatment had longer QT intervals than did the healthy volunteers, but antipsychotics prolonged the QT interval regardless of the correction method used (P<0.01). Schizophrenic patients with and without medication had a significantly higher mean heart rate than did the healthy volunteers, with no obvious sex-related differences in the QT interval. The QT interval prolongation may be manifestation of a certain biological feature of schizophrenia.
An increased incidence of sudden death has been observed among patients treated with antidepressants. A prolonged QTc interval is a known prognostic factor for fatal arrhythmia, and several studies have shown that the use of antidepressants can cause a prolonged QTc interval. However, few studies, especially in Japan, have compared the effects of multiple drugs on QTc interval or examined dose relationships in a clinical setting.We compared the effects of antidepressants on QT interval, corrected to QTc by Bazett's formula, in 729 Japanese patients who were diagnosed with mood disorder.Using stepwise multiple linear regression analysis, we found that the use of tricyclic antidepressants (P<0.01) and concomitant use of antipsychotics (P<0.05), as well as advanced age and being female (known factors for prolonged QTc interval; both P<0.01), significantly prolonged the QTc interval. Analysis of individual antidepressants also revealed that the use of clomipramine (P<0.01) and amitriptyline (P<0.05) significantly prolonged the QTc interval.Our results reveal that tricyclic antidepressants, especially clomipramine and amitriptyline, confer a risk of prolonged QTc interval in a dose-dependent manner. The selective serotonin reuptake inhibitors investigated (fluvoxamine, paroxetine, sertraline) were not indicated as risk factors for QTc prolongation.
BACKGROUND: Recent pharmacoepidemiology data show an increase in the
proportion of patients receiving second-generation antipsychotic (SGA)
monotherapy, but no studies have analyzed the same patients over a long
period of time. Therefore, in this study, we decided to evaluate
retrospectively schizophrenia patients with available data for 20 years
to see whether the drug treatments in the same patients have changed in
the past 20 years. METHODS: The study began in April 2021 and was
conducted in 15 psychiatric hospitals in Japan. Schizophrenia patients
treated in the same hospital for 20 years were retrospectively examined
for all prescriptions in 2016, 2011, 2006, and 2001 (i.e., every 5
years). RESULTS: The mean age of the 716 patients surveyed in 2021 was
61.7 years, with 49.0% being female. The rate of antipsychotic
monotherapy use showed a slight increasing trend over the past 20 years;
the rate of SGA use showed a marked increasing trend from 28.9% to
70.3% over the past 20 years, while the rate of SGA monotherapy use
showed a gradual increasing trend over the past 20 years. The rates of
concomitant use of anticholinergics, antidepressants, anxiolytics/sleep
medications, and mood stabilizers showed decreasing, flat, decreasing,
and flat trends over the past 20 years, respectively. CONCLUSION: The
results of this study showed a slow but steady substitution of SGAs for
first-generation antipsychotics (FGAs) over time, even in the same
patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.